424B4PROSPECTUS
Sep 30, 2026Final prospectus0001213900-26-104917
All companies
Trade Newgenivf Group Ltd
NE
Newgenivf Group Ltd
NIVFPublic
PublicUnited States(Nasdaq)Best valuation $359.86K1 market
Public listing
Listed· Nasdaq· Listing market: United StatesListing date
Not available
Offer price
Not available
Shares offered
Not available
Offering proceeds
Not available
Sources: sec-edgar, sec-harvest, nasdaq
IPO Calendar · NasdaqIPO
NIVFPrice
$0.1290
24h
+27.72%
Valuation
$359.86K
24h volume
$39.12M
Type
IPO
Trade Newgenivf Group LtdNow trading publicly. Buy via a broker — opens in a new tab.
IPO Calendar · updated 2h ago
Financials
ProfitableFrom SEC filings, latest FY ending Dec 31, 2025 · CIK 0001981662.
Revenue · -13.01% YoY
$4.73M
Net income
$9.88M
Gross margin
20.22%
Cash
$758.62K
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $4.73M | $5.43M | $5.14M | $5.94M | $4.12M |
| Gross profit | $955.85K | $1.83M | $1.68M | $1.54M | $1.02M |
| Operating income | -$10.73M | -$1.16M | $42.24K | $398.71K | $198.76K |
| Net income | $9.88M | -$524.64K | $130.19K | $458.67K | -$533 |
| Cash & equivalents | $758.62K | $457.74K | $54.1K | $27.56K | — |
| Total assets | $32.72M | $3.58M | $4.49M | $2.9M | — |
| Total liabilities | $6.74M | $5.06M | $1.24M | $2.8M | — |
| Shareholders' equity | $26.63M | -$1.05M | $3.74M | $563.11K | — |
SEC IPO filings
Final prospectusEDGAR filings resolved from NIVF / CIK 0001981662.
Sep 28, 2026Effective9999999995-26-003079
Sep 10, 2026Amended0001213900-26-098823
Sep 1, 2026Amended0001213900-26-096245
Aug 20, 2026Filed0001213900-26-091922
Jul 13, 2026Confidential draft0001213900-26-077367
May 12, 2026Withdrawn0001213900-26-055052
Mar 13, 2026Effective9999999995-26-000818
424B3PROSPECTUS
Mar 13, 2026Final prospectus0001213900-26-027267
Mar 2, 2026Filed0001213900-26-022470
Feb 4, 2026Confidential draft0001213900-26-011851
424B3PROSPECTUS
Oct 31, 2025Final prospectus0001213900-25-104469
Newgenivf Group Ltd IPO — frequently asked questions
- When did Newgenivf Group Ltd go public?
- Newgenivf Group Ltd has already gone public and now trades publicly on Nasdaq under the ticker NIVF.
- Can I buy Newgenivf Group Ltd stock?
- Yes — Newgenivf Group Ltd is publicly traded on Nasdaq as NIVF. You can follow its live price, valuation and post-IPO performance above.
- What is Newgenivf Group Ltd's valuation?
- Newgenivf Group Ltd's most recent valuation tracked here is $359.86K, derived from live market prices.